Bliss Gvs Pharma Ltd vs Haleos Labs Limited Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Jun 15, 2026

Key Highlights

The Latest Trading Price of Bliss GVS Pharma Ltd is ₹ 438.1 as of 12 Jun 15:30 . The P/E Ratio of Bliss GVS Pharma Ltd changed from 14.9 on March 2021 to 14.7 on March 2025 . This represents a CAGR of -0.27% over 5 yearsThe P/E Ratio of Haleos Labs Limited changed from 11 on March 2021 to 16.2 on March 2025 . This represents a CAGR of 8.05% over 5 years The Market Cap of Bliss GVS Pharma Ltd changed from ₹ 1018 crore on March 2021 to ₹ 1238 crore on March 2025 . This represents a CAGR of 4.00% over 5 yearsThe Market Cap of Haleos Labs Limited changed from ₹ 149.61 crore on March 2021 to ₹ 326.64 crore on March 2025 . This represents a CAGR of 16.90% over 5 years The revenue of Bliss GVS Pharma Ltd for the Mar '26 is ₹ 268.18 crore as compare to the Dec '25 revenue of ₹ 236.71 crore. This represent the growth of 13.29% The revenue of Haleos Labs Limited for the Mar '26 is ₹ 77.15 crore as compare to the Dec '25 revenue of ₹ 94.97 crore. This represent the decline of -18.76% The ebitda of Bliss GVS Pharma Ltd for the Mar '26 is ₹ 55.63 crore as compare to the Dec '25 ebitda of ₹ 50.73 crore. This represent the growth of 9.66% The ebitda of Haleos Labs Limited for the Mar '26 is ₹ 6.17 crore as compare to the Dec '25 ebitda of ₹ 14.23 crore. This represent the decline of -56.64% The net profit of Bliss GVS Pharma Ltd changed from ₹ 22.11 crore to ₹ 37 crore over 8 quarters. This represents a CAGR of 29.36% The net profit of Haleos Labs Limited changed from ₹ 7.1 crore to ₹ 0.34 crore over 8 quarters. This represents a CAGR of -78.12% The Dividend Payout of Bliss GVS Pharma Ltd changed from 7.64 % on March 2021 to 7.64 % on March 2025 . This represents a CAGR of 0.00% over 5 yearsThe Dividend Payout of Haleos Labs Limited changed from 3.44 % on March 2021 to 2.12 % on March 2025 . This represents a CAGR of -9.23% over 5 years .

About Bliss GVS Pharma Ltd

Bliss GVS Pharma Limited was originally incorporated as a Private Limited Company in the name of Bliss Chemicals & Pharmaceuticals India Private Limited in 1984.
The status converted into a Public Limited Company and the name of the Company was changed to Bliss Chemicals & Pharmaceuticals India Limited and further to Bliss GVS Pharma Limited on May 12, 2006. The Company is engaged in manufacturing, marketing, trading and export of pharmaceutical products.
The Company has its manufacturing facility at Palghar which is WHO GMP approved.
The business operates five cutting-edge production facilities that adhere to WHO-GMP, EU-MP, ISO 14001 and OHSAS 45001 standards. The company commenced its business in 1985.
In 1994 the company introduced a new pharmaceutical product VAGID. During the financial year ended 31 March 2014, Bliss GVS Pharma's R&D center, received approval from Government of India's Department for Scientific & Industrial Research (DSIR).

About Haleos Labs Limited

SMS Lifesciences India Limited was incorporated originally as 'Potluri Real Estate Private Limited' on May 31, 2006.
The Company's name was changed to 'Potluri Packaging Industries Private Limited' on 6 November, 2013 and again changed to 'SMS Lifesciences India Private Limited on 4 August, 2014 to undertake the activities related pharma sector.
The Company became a wholly owned subsidiary Company of SMS Pharmaceuticals Limited w.e.f. 01.04.2016 and subsequently got converted into a Public Limited w.e.f. 22 June, 2016. The Company is engaged in the business of manufacturing and export of Active Pharma Ingredients(APIs) and their intermediates.
The Company is having manufacturing facilities at Kazipally and Jeedimetla, Hyderabad with an installed capacity of 65 KL. What started off as a single facility - single product manufacturing company in 1990 grew to be a multi-location group having products spread across an array of therapeutic segments.

FAQs for the comparison of Bliss GVS Pharma Ltd and Haleos Labs Limited

Which company has a larger market capitalization, Bliss GVS Pharma Ltd or Haleos Labs Limited?

Market cap of Bliss GVS Pharma Ltd is 4,646 Cr while Market cap of Haleos Labs Limited is 409 Cr

What are the key factors driving the stock performance of Bliss GVS Pharma Ltd and Haleos Labs Limited?

The stock performance of Bliss GVS Pharma Ltd and Haleos Labs Limited is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Bliss GVS Pharma Ltd and Haleos Labs Limited?

As of June 15, 2026, the Bliss GVS Pharma Ltd stock price is INR ₹438.1. On the other hand, Haleos Labs Limited stock price is INR ₹1356.0.

How do dividend payouts of Bliss GVS Pharma Ltd and Haleos Labs Limited compare?

To compare the dividend payouts of Bliss GVS Pharma Ltd and Haleos Labs Limited, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.